shutterstock_2055997766_michael_vi

Michael Vi / Shutterstock.com

4 August 2022MedtechStaff Writer

J&J unit primed for multi-million dollar damages over counterfeits

Judge urges $18m award in ‘horrific’ counterfeiting case | Counterfeits were ‘bacterially contaminated’ | Ethicon.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

More on this story

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

More on this story

US govt bodies unite to battle fake pharma

22 December 2022 Counterfeit medicine and drugs cause more than one million deaths a year | Trio of bodies will work jointly together | National Intellectual Property Rights Coordination Center | Homeland Security Investigations.

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

J&J units launch prostate cancer drug suit

31 May 2022 Johnson & Johnson subsidiaries Aragon Pharmaceuticals and Janssen Biotech have sued three pharma companies for alleged infringement of five patents relating to prostate cancer treatment Erleada.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent